These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3311222

  • 21. Transcription factor CP2 is crucial in hemoglobin synthesis during erythroid terminal differentiation in vitro.
    Chae JH, Lee YH, Kim CG.
    Biochem Biophys Res Commun; 1999 Sep 24; 263(2):580-3. PubMed ID: 10491335
    [Abstract] [Full Text] [Related]

  • 22. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G, Rekhtman N, Cheng G, Krasikov T, Skoultchi AI.
    Oncogene; 1997 Jan 09; 14(1):123-31. PubMed ID: 9010239
    [Abstract] [Full Text] [Related]

  • 23. Role of differentiation induction in tumor suppression.
    Marks PA, Rifkind RA.
    Immunol Ser; 1990 Jan 09; 51():201-16. PubMed ID: 2095918
    [No Abstract] [Full Text] [Related]

  • 24. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ.
    Exp Hematol; 1993 Jan 09; 21(1):169-76. PubMed ID: 8417953
    [Abstract] [Full Text] [Related]

  • 25. Hexamethylenebisacetamide-mediated induction of murine erythroleukemia cells: relationship between expression of beta major and beta minor globin genes, globin mRNA synthesis and commitment to erythroid differentiation.
    Gambari R.
    Biochem Int; 1983 Oct 09; 7(4):471-80. PubMed ID: 6679742
    [Abstract] [Full Text] [Related]

  • 26. Regulation of globin gene expression during induced erythroid cell differentiation.
    Rifkind RA, Sheffery M, Profous-Juchelka HR, Reuben RC, Marks PA.
    Prog Clin Biol Res; 1983 Oct 09; 134():183-92. PubMed ID: 6582518
    [Abstract] [Full Text] [Related]

  • 27. [Commitment to erythroid differentiation and globin gene expression in the absence of heme accumulation in Friend leukemia cells].
    Gambari R.
    Boll Soc Ital Biol Sper; 1983 May 30; 59(5):631-7. PubMed ID: 6882562
    [Abstract] [Full Text] [Related]

  • 28. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM, Miyazaki K, Takeyama H, Sherman ML, Spriggs DR, Carney WP, Kufe DW.
    Cancer Commun; 1989 May 30; 1(3):191-7. PubMed ID: 2639729
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Differentiation and malignant suppression induced by mouse erythroid differentiation and denucleation factor on mouse erythroleukemia cells].
    Zhao Q, Ge YH, Zhou JP, Ma J, Chen KQ, Xue SP, Han DS.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb 30; 23(1):32-5. PubMed ID: 12905814
    [Abstract] [Full Text] [Related]

  • 32. Gene expression during terminal differentiation: dexamethasone suppression of inducer-mediated alpha 1- and beta maj-globin gene expression.
    Kaneda T, Murate T, Sheffery M, Brown K, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1985 Aug 30; 82(15):5020-4. PubMed ID: 3860841
    [Abstract] [Full Text] [Related]

  • 33. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T, Sherman M, Shafman T, Iwata T, Kufe D.
    J Cell Physiol; 1986 Jun 30; 127(3):480-4. PubMed ID: 3458709
    [Abstract] [Full Text] [Related]

  • 34. Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiation.
    Leng L, Yu F, Dong L, Busquets X, Osada S, Richon VM, Marks PA, Rifkind RA.
    Cancer Res; 1993 Nov 15; 53(22):5554-8. PubMed ID: 8221697
    [Abstract] [Full Text] [Related]

  • 35. [Relationship between expression of c-myc and P53 genes and terminal differentiation during induced differentiation in Friend erythroleukemia cells].
    Liu HT, Zhang HQ, Xue SB, Du CY, You JS, Song PG, Wang XL, Chen RX.
    Shi Yan Sheng Wu Xue Bao; 1988 Sep 15; 21(3):311-9. PubMed ID: 3066081
    [No Abstract] [Full Text] [Related]

  • 36. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment.
    Coppola JA, Cole MD.
    Nature; 1988 Sep 15; 320(6064):760-3. PubMed ID: 3458027
    [Abstract] [Full Text] [Related]

  • 37. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
    Aroor AR, Singh LP, Wahba AJ.
    Exp Hematol; 1995 Oct 15; 23(11):1204-11. PubMed ID: 7556531
    [Abstract] [Full Text] [Related]

  • 38. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP, Holmes KL, Morse HC, Thorgeirsson SS.
    Exp Cell Res; 1988 Oct 15; 178(2):185-98. PubMed ID: 2458948
    [Abstract] [Full Text] [Related]

  • 39. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z, Banks J, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1982 Jan 15; 79(2):471-5. PubMed ID: 6952199
    [Abstract] [Full Text] [Related]

  • 40. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation.
    Todokoro K, Ikawa Y.
    Biochem Biophys Res Commun; 1986 Mar 28; 135(3):1112-8. PubMed ID: 3457564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.